- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (474)
- Timeline of Article Publication (1)
- Authors Evaluation (2)
- Article Quality Tracking (0)
- Reference Citation Analysis (3)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9221)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2023 (publication date) through Jul 11, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huang KY, Wang FY, Lv M, Ma XX, Tang XD, Lv L. Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment. World J Gastroenterol 2023; 29(26): 4120-4135 [PMID: 37475846 DOI: 10.3748/wjg.v29.i26.4120] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i26/4120.htm |
| Number | Citing Articles |
| 1 |
Sulaiman A Alshammari, Mohsen N Almutairi, Mohammad O Alomar, Ziyad M Alsherif, Faisal H Alsubaie, Abdulrahman I Almezaini. Overlap Between Gastroesophageal Reflux Disease and Irritable Bowel Syndrome and Its Impact on Quality of Life. Cureus 2023; doi: 10.7759/cureus.50840
|
| 2 |
Jerlin Stephy JohnBritto, Agostino Di Ciaula, Antonino Noto, Velia Cassano, Angela Sciacqua, Mohamad Khalil, Piero Portincasa, Leonilde Bonfrate. Gender-specific insights into the irritable bowel syndrome pathophysiology. Focus on gut dysbiosis and permeability. European Journal of Internal Medicine 2024; 125: 10 doi: 10.1016/j.ejim.2024.03.011
|
| 3 |
I.Ya. Hospodarskyy, L.A. Hryshchuk, T.V. Boyko. The possibility of Bacillus probiotic use in patients with post-infectious irritable bowel syndrome after COVID-19 infection. GASTROENTEROLOGY 2024; 58(2): 121 doi: 10.22141/2308-2097.58.2.2024.605
|
| 4 |
Omid Vakili, Peyman Adibi Sedeh, Morteza Pourfarzam. Metabolic biomarkers in irritable bowel syndrome diagnosis. Clinica Chimica Acta 2024; 560: 119753 doi: 10.1016/j.cca.2024.119753
|
| 5 |
Bernhard Uehleke, Martin Storr, Martin Hörning. Grapefruit Seed Extract Reduces Gastrointestinal
Symptoms. Zeitschrift für Phytotherapie 2024; 45(02): 54 doi: 10.1055/a-2194-2206
|
| 6 |
Jun Zhao, Xia Li, Jiayi Yang, Xin Hao, Junjian Tian, Xin Wang, Xuefei Wang, Ning Li, Zhigang Li. Prevalence of and factors associated with symptoms consistent with a diagnosis of irritable bowel syndrome among resident physicians in standardised training in China: a cross-sectional study. BMJ Open 2023; 13(12): e079874 doi: 10.1136/bmjopen-2023-079874
|
| 7 |
Hongxiu Chen, Zhifang Xu, Honggang Zhao, Jiazhen Cao, Rui Wang, Jing He, Ru Nie, Jialin Jia, Shuting Yuan, Yonghong Li, Zhicheng Liu, Xinyu Zhang, Lijuan Ha, Xiaoru Xu, Tie Li. Global research states and trends of micro RNA in irritable bowel syndrome: a bibliometric analysis. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01396-y
|
| 8 |
Alexey M. Osadchuk, Irina D. Loranskaya, Mikhail A. Osadchuk. Comorbid functional pathology in gastroenterology. Possibilities and prospects for drug treatment: A review. Consilium Medicum 2024; 25(12): 844 doi: 10.26442/20751753.2023.12.202529
|
| 9 |
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi. Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what’s new?. Expert Opinion on Drug Metabolism & Toxicology 2024; 20(5): 307 doi: 10.1080/17425255.2024.2348488
|
| 10 |
Wei-Hao Chai, Yan Ma, Jia-Jia Li, Fei Guo, Yi-Zhan Wu, Jiang-Wei Liu. Immune cell signatures and causal association with irritable bowel syndrome: A mendelian randomization study. World Journal of Clinical Cases 2024; 12(17): 3094-3104 doi: 10.12998/wjcc.v12.i17.3094
Abstract(73) |
Core Tip(72) |
Full Article(HTML)(555)
|
Full Article with Cover (PDF)-9912K(11)
|
Full Article (Word)-1350K(0)
|
Audio-684K(0)
|
Peer-Review Report-195K(9)
|
Answering Reviewers-104K(7)
|
Full Article (PDF)-9454K(14)
|
Full Article (XML)-117K(8)
|
Times Cited (0)
|
Total Visits (1168)
|
Open
|
| 11 |
Olga Biniszewska, Damian Jacenik, Aleksandra Tarasiuk, Jakub Fichna. Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 2024; 25(8): 1039 doi: 10.1080/14656566.2024.2366993
|